Table 2.
Comparison of the clinical parameters between the H-immunity and L-immunity groups in PTC.
| Clinical parameters | H-immunity (n = 293, %) | L-immunity (n = 209, %) | p-value |
|---|---|---|---|
| Age (y) | |||
| <55 | 199 (67.9) | 136 (65.1) | 0.505 |
| ≥55 | 94 (32.1) | 73 (34.9) | |
| Gender | |||
| Female | 215 (73.4) | 152 (72.7) | 0.871 |
| Male | 78 (26.6) | 57 (27.3) | |
| Stage | |||
| I | 161 (54.9) | 120 (58.0) | 0.001 |
| II | 19 (6.5) | 33 (15.9) | |
| III | 76 (25.9) | 36 (17.4) | |
| IV | 37 (12.6) | 18 (8.7) | |
| NA | 0 | 2 | |
| Metastasis | |||
| M0 | 184 (97.9) | 98 (95.1) | 0.199 |
| M1 | 4 (2.1) | 5 (4.9) | |
| NA | 105 | 106 | |
| N classification | |||
| N0 | 123 (43.9) | 106 (61.6) | <0.001 |
| N1 | 157 (56.1) | 66 (38.4) | |
| NA | 13 | 37 | |
| T classification | |||
| T1 | 87 (29.8) | 56 (26.9) | 0.018 |
| T2 | 80 (27.4) | 84 (40.4) | |
| T3 | 109 (37.3) | 61 (29.3) | |
| T4 | 16 (5.5) | 7 (3.4) | |
| NA | 1 | 1 | |
| Radiation therapy | |||
| Yes | 175 (62.7) | 130 (64.0) | 0.767 |
| No | 104 (37.3) | 73 (36.0) | |
| NA | 14 | 6 | |
| Pathological type | |||
| Classical | 231 (78.8) | 125 (59.8) | <0.001 |
| Follicular | 23 (7.8) | 78 (37.3) | |
| Tall cell | 35 (11.9) | 1 (0.5) | |
| Other | 4 (1.4) | 5 (2.4) | |
| BRAF | |||
| Wild-type | 63 (22.4) | 132 (65.7) | <0.001 |
| Mutated | 218 (77.6) | 69 (34.3) | |
| NA | 12 | 8 | |
| RAS | |||
| Wild-type | 275 (97.9) | 147 (73.1) | <0.001 |
| Mutated | 6 (2.1) | 54 (26.9) | |
| NA | 12 | 8 |